responded that they would prefer to go to a practice with a VISIA system compared to a practice without VISIA. Sixty-two percent of respondents noted that they would pay for the analysis with the VISIA system. Thirty-eight percent of subjects responded that the analysis guided their product purchases or treatment decisions.
Conclusion
The VISIA Complexion Analysis System is a beneficial tool for dermatology and aesthetic practices. It has the potential to help patients understand their skin concerns and guide treatment decisions. While not addressed in this study, we have used the VISIA in our clinical practice to perform baseline evaluations and track treatment outcomes. This study is limited by the small number of subjects. Further studies on how to integrate the VISIA system into a clinical practice are warranted.
Disclosures
The authors have no relevant commercial interests to disclose.
References
- Pandya AG, Hynan LS, Bhore R, Riley FC, Guevara IL, Grimes P, et al. Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. JAAD. 2011;64(1):78-83, .e1-2.
- VISIA Complexion Analysis System: Frequently Asked Questions. Canfield Imaging Systems, Fairfield, NJ.
- Demirli R, Otto P, Viswanathan R, Patwardhan S, Larkey J. RBX Technology Overview. Canfield Imaging Systems, Fairfield, NJ.
- Cygler, Kathleen. VISIA Complexion Analysis Med Spa [Webinar]. Recorded Nov 5, 2013. Accessed May 16, 2014. https://www1.gotomeeting.com/register/783169248.
AUTHOR CORRESPONDENCE
C. William Hanke MD MPH…......................................cwmhanke@thelassi.com
